Literature DB >> 9843835

A new integrative method to quantify total Ca2+ handling and futile Ca2+ cycling in failing hearts.

J Shimizu1, J Araki, J Mizuno, S Lee, Y Syuu, S Hosogi, S Mohri, T Mikane, M Takaki, T W Taylor, H Suga.   

Abstract

Ca2+ handling in excitation-contraction coupling requires considerable O2 consumption (VO2) in cardiac contraction. We have developed an integrative method to quantify total Ca2+ handling in normal hearts. However, its direct application to failing hearts, where futile Ca2+ cycling via the Ca2+-leaky sarcoplasmic reticulum (SR) required an increased Ca2+ handling VO2, was not legitimate. To quantify total Ca2+ handling even in such failing hearts, we combined futile Ca2+ cycling with Ca2+ handling VO2 and the internal Ca2+ recirculation fraction via the SR. We applied this method to the canine heart mechanoenergetics before and after intracoronary ryanodine at nanomolar concentrations. We found that total Ca2+ handling per beat was halved after the ryanodine treatment from approximately 60 micromol/kg left ventricle before ryanodine. We also found that futile Ca2+ cycling via the SR increased to >1 cycle/beat after ryanodine from presumably zero before ryanodine. These results support the applicability of the present method to the failing hearts with futile Ca2+ cycling via the SR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843835     DOI: 10.1152/ajpheart.1998.275.6.H2325

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Myocardial mechanical restitution and potentiation partly underlie alternans decay of postextrasystolic potentiation: simulation.

Authors:  S Mohri; J Araki; T Imaoka; G Iribe; M Maesako; J Shimizu; H Matsubara; T Ohe; M Hirakawa; H Suga
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Total Ca handling in canine mild Ca overload failing heart.

Authors:  J Mizuno; J Araki; G Iribe; M Maesako; T Morita; K Miyaji; T Imaoka; S Mohri; S Sano; T Ohe; M Hirakawa; H Suga
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.